DCA Officials Seize ‘Diclojan Forte’ Tab For Misleading Claims

HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘DICLOJAN Forte Tablets (Diclofenac Sodium & Paracetamol Tablets),’ in Aiza Village, Jogulamba-Gadwal District, for making a misleading advertisement claiming it treats ‘fever.

In a statement here on Thursday, DCA Director-General VB Kamalasan Reddy said that the officials detected a medicine ‘DICLOJAN Forte Tablets’ circulating in the market with misleading claim on its label that it treats ‘fever’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. During the special raids conducted on 24th, and 25th April, officials from the Drugs Control Administration, Mahabubnagar Zone, detected ‘DICLOJAN Forte Tablets’. The said medicine was detected by DCA officials at a medical shop situated in Aiza Village, Aiza Mandal, Jogulamba-Gadwal District. Stocks were seized during the raid.

The advertisement of a medicine for the treatment of ‘fever’ in general is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Mohd. Rafhi Shaik, Drugs Inspector, Gadwal and A.N. Kranthi Kumar, Drugs Inspector, Narayanpet are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

Persons who make misleading advertisements regarding drugs for treatment of certain diseases and disorders are punishable under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, with imprisonment which may extend to six months, or with fine, or with both.

The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.

Related Posts

  • Pharma
  • May 16, 2025
  • 44 views
Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has launched Ureaderm 10% and 20%, a new range of urea-based moisturizers designed to address severe dryness…

  • Pharma
  • May 16, 2025
  • 68 views
DCA seizes syrup stocks over misleading fever cure claim

Officials from the Telangana Drugs Control Administration (DCA) have seized stocks of a syrup marketed as a cure for ‘all types of fevers’, citing violation of the Drugs and Magic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs